Anticarcinogenic impact of interferon therapy on the propression of hepatocellular carcinoma in patients with chronic viral infection
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-01-01
著者
-
Nishiguchi Shuhei
Division Of Hepatobiliary And Pancreatic Disease Department Of Internal Medicine Hyogo College Of Me
-
SHIMOMURA Soji
Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine
関連論文
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K_2
- Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene
- Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor
- Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus
- Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease : A case-control study
- Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
- TRENDS IN THE CAUSES AND OUTCOME OF LIVER CIRRHOSIS DIAGNOSED BY LAPAROSCOPY IN OSAKA, JAPAN DURING THE PAST THREE DECADES